Medical Update in TB Control #1: Management of Tuberculosis in Patients Taking TNF-Alpha Inhibitors
|
|
Wednesday, September 16, 2009
1:00 PM - 2:30 PM, EST
CME/CNE Certified Training Course
New Jersey Medical School Global Tuberculosis Institute
225 Warren St., 1st Floor, West Wing Newark, New Jersey
www.umdnj.edu/globaltb
Sponsored by
University of Medicine & Dentistry of New Jersey (UMDNJ), New Jersey Medical School Global Tuberculosis Institute, and UMDNJ-Center for Continuing and Outreach Education
|
|
This program is an activity of
 |
| |
| The management of patients infected with M. tuberculosis in the presence of an immunocompromising condition can be complicated and challenging. This web-based seminar will specifically cover screening, diagnosis, treatment, and management of patients who are taking anti-tumor necrosis factor agents (TNF-alpha inhibitors). The seminar will consist of an overview of the interaction between TNF-alpha inhibitors and TB infection and disease and review the latest CDC recommendations for physicians prescribing these agents as well as for physicians diagnosing and treating TB in patients already taking TNF-alpha inhibitors. Case presentations will be included along with time for discussion. |
| Physicians and other health care professionals who manage patients with co-morbidities that may lead to treatment with TNF-alpha inhibitors and/or patients with TB infection or disease. |
|
Upon completion of this seminar, participants will be able to:
- Determine the role of immunosuppressive therapies in the course of infection with TB in order better diagnose and treat TB patients with a condition requiring treatment with TNF-alpha inhibitors.
- Utilize CDC recommendations for screening, diagnosis, and treatment of latent TB infection and TB disease in patients taking TNF-alpha inhibitors in order to avoid development of complications related to the development of TB in those infected and the cure of active TB disease.
- Apply lessons learned from reviewing TB treatment challenges when managing patients taking TNF-alpha inhibitors to avoid diagnostic and treatment failures.
|
|
1:00pm Introduction - Lee Reichman, MD, MPH
1:10pm Overview of TB Pathogenesis & Treatment in Persons Taking TNF-Alpha Inhibitors - Lynelle, Philipps, RN, MPH
1:45pm Case Presentation: Treatment of a Patient on TNF-Alpha Inhibitors - Germaine Jacquette, MD
2:20pm Discussion
2:25pm Concluding remarks - Lee Reichman, MD, MPH
|
|
NJMS Global TB Institute
Newark, NJ
Germaine Jacquette, MD
Physician Specialist
Lee Reichman, MD
Executive Director
Heartland National TB Center/Univ. of Missouri
Columbia, MO
Lynelle Phillips, RN, MPH
Nurse Consultant
|
| Registration priority will be given to individuals within the Northeastern Region, including Connecticut, Delaware, District of Columbia, Indiana, Maine, Maryland, Massachusetts, Michigan, New Hampshire, New Jersey, New York, Ohio, Pennsylvania, Rhode Island, Vermont and West Virginia, and the cities of Baltimore, Detroit, New York City and Philadelphia. Participants must have Internet access (high-speed preferred), a speaker phone, and an email address to receive course information. There is no limit to the number of participants at one site. However, sites must identify a contact person to receive conference information and collect and submit completed evaluation forms and sign-in sheet. |
|
Please complete the registration process online by clicking here. If a group is participating together in the same room, only one person in the group should register.
You will receive notification of acceptance of your registration at least 2 weeks prior to the seminar date. All communication for this event will be done via email. Please check the spelling of your email address carefully during registration and be sure to check you spam/bulk mail boxes as some information may filter into these boxes.
|
| This conference is free; however, there is a $10 charge per person for Continuing Education Credits. Participants may sign up for credits on the sign-in sheet which will be emailed just prior to the conference. Payment must be received within one week of the program. |
|
ACTIVITY DIRECTOR
NJMS Global TB Institute
Newark, NJ
Nisha Ahamed, MPH
Program Director, Education and Training
MEMBERS
NJMS Global TB Institute
Newark, NJ
Rajita Bhavaraju, MPH
Training and Consultation Specialist
Germaine Jacquette, MD
Physician Specialist
Lauren Moschetta-Gilbert, MA
Training and Consultation Specialist
Heartland National TB Center/Univ. of Missouri Columbia, MO
Lynelle Phillips, RN, MPH
Nurse Consultant
|
|
The University of Medicine and Dentistry of New Jersey – Center for Continuing and Outreach Education (UMDNJ-CCOE) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing education for physicians.
University of Medicine and Dentistry of New Jersey – Center for Continuing and Outreach Education (UMDNJ-CCOE) designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
University of Medicine and Dentistry of New Jersey-Center for Continuing and Outreach Education (UMDNJ-CCOE) is an approved provider of continuing nursing education by NJSNA, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is awarded 1.5 contact hours (60 minute CH).
Provider approved by the California Board of Registered Nursing, Provider Number CEP 13780.
|
| UMDNJ reserves the right to modify the activity content, faculty and activities, and reserves the right to cancel this activity, if necessary. |
If you have any additional questions, please contact Rajita Bhavaraju at (973) 972-4811 or email at bhavarrr@umdnj.edu
|
